+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Correlation of Bone Mineral Density Scores and Proton Pump Inhibitors Use in the Elderly



Correlation of Bone Mineral Density Scores and Proton Pump Inhibitors Use in the Elderly



Current Rheumatology Reviews 12(2): 162-166



We aimed to identify any correlation between long-term proton pump inhibitor use and low bone mineral density in the elderly. This is a retrospective cohort study looking at PPI usage and bone mineral density scores of patients age 65 and above within a period of two years. Lumbar spine, right hip, and left hip bone mineral density t-scores were reviewed in PPI users and non-users. A total of 1,016 patients who had bone mineral density scans within that period were identified. Non-adjusted data showed no statistically significant association between PPI users and non-users in lumbar spine (p = 0.903), right hip (p = 0.775) and left hip (p = 0.407) bone mineral density scores. After adjusting for age and gender, PPI use was still not associated with low bone mineral density at the lumbar spine (p = 0.957), right hip (p = 0.440), or left hip (p = 0.691). The logistic regression did not show a statistically significant difference in low bone mineral density scores in lumbar spine (p = 0.162), right hip (p = 0.796), and left hip (p = 0.196) when length of use was considered. Among adults 65 years and older proton pump inhibitors users; there appears to be no correlation between PPI use and low bone mineral density and/or the length of PPI use.

(PDF emailed within 1 workday: $29.90)

Accession: 057520806

Download citation: RISBibTeXText

PMID: 26496778


Related references

Proton pump inhibitors use and change in bone mineral density. International Journal of Rheumatic Diseases 19(9): 864-868, 2017

Effect of long-term proton pump inhibitors on bone mineral density. La Tunisie Medicale 96(3): 193-197, 2018

Fracture risk and bone mineral density reduction associated with proton pump inhibitors. PharmacoTherapy 32(1): 67-79, 2012

Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors. Biomedical Reports 5(2): 165-170, 2016

Proton pump inhibitors do not induce change in bone mineral density in a long-term observational study. Evidence-Based Medicine 18(5): 192-193, 2014

Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study. Journal of Bone and Mineral Research 30(2): 232-239, 2016

Bone density in proton pump inhibitors users: a prospective study. Rheumatology International 33(9): 2255-2260, 2014

Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology 138(3): 896-904, 2010

Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole. Biochemical Pharmacology 58(8): 1349-1359, Oct 15, 1999

Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals. Bone 57(2): 437-442, 2014

Long-term therapy with proton pump inhibitors is associated with decreased bone density. Medical Hypotheses 72(5): 608-609, 2009

Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients. International Journal of Clinical Practice 63(2): 261-268, 2010

The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures. Journal of Clinical Endocrinology and Metabolism 100(3): 1018-1027, 2015

Measurement of vertebral bone marrow lipid profile at 1.5-T proton magnetic resonance spectroscopy and bone mineral density at dual-energy X-ray absorptiometry: correlation in a swine model. Skeletal Radiology 43(8): 1123-1128, 2015

Bone Mineral Density T-Scores Derived from CT Attenuation Numbers (Hounsfield Units): Clinical Utility and Correlation with Dual-energy X-ray Absorptiometry. Iowa Orthopaedic Journal 38: 25-31, 2018